RESECTABLE PANCREATIC CANCER
Clinical trials for RESECTABLE PANCREATIC CANCER explained in plain language.
Never miss a new study
Get alerted when new RESECTABLE PANCREATIC CANCER trials appear
Sign up with your email to follow new studies for RESECTABLE PANCREATIC CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug combo aims to shrink pancreatic tumors before surgery
Disease control OngoingThis early-phase trial tests whether adding a targeted drug called ivosidenib to standard chemotherapy can help shrink pancreatic tumors before surgery. About 16 people with resectable pancreatic cancer that has a specific gene mutation (IDH1) will receive the drug combination fo…
Matched conditions: RESECTABLE PANCREATIC CANCER
Phase: PHASE1 • Sponsor: Case Comprehensive Cancer Center • Aim: Disease control
Last updated Jun 26, 2026 13:51 UTC
-
Can a simple test guide chemo for pancreatic cancer patients?
Knowledge-focused OngoingThis study looks at whether a biomarker called GATA6 can help predict how well patients with resectable pancreatic cancer respond to chemotherapy before and after surgery. About 84 participants will provide tumor samples to measure GATA6 levels, then receive a standard chemo regi…
Matched conditions: RESECTABLE PANCREATIC CANCER
Phase: NA • Sponsor: University Health Network, Toronto • Aim: Knowledge-focused
Last updated Jun 27, 2026 11:01 UTC